Portal Biotech

📍 London, United Kingdom👥 24 employees💰 Last funded Jul 2022
Biotechnology Research🌐 portalbiotech.com
Website LinkedIn
Portal is revolutionising biosensing by bringing precise and universal proteomics and metabolomics to the bench-top. Proteins are the functional unit of biology, involved in every pathway and reaction, every synthesis and chemical modification, that make life possible. To understand proteins and metabolites is to understand ourselves: how we work, our health, how our bodies respond to treatments and interventions. Nanopores are nature’s biosensor — molecular devices with an exquisite sensitivity honed over billions of years of evolution. By using our deep expertise in bioengineering and machine-learning to improve on the remarkable properties of biological nanopores, and combining with our unique microelectronics, our products provide category-defining biological insight on a single-molecule basis. Portal, Portal Biotech and Portal Biotechnologies are trading names of Portal Biotechnology Limited.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Portal Biotech?
Portal Biotech has 1 investors on record on gritt.io.
When did Portal Biotech last raise funding?
The most recent investment in Portal Biotech recorded on gritt.io was in July 2022.
What industry is Portal Biotech in?
Portal Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Portal Biotech based?
Portal Biotech is headquartered in London, United Kingdom.